The global sclerotherapy needle market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The market is driven by factors such as increasing prevalence of chronic venous insufficiency and varicose veins, rising awareness about the benefits of sclerotherapy treatment, and growing demand for minimally invasive procedures.
The global sclerotherapy needle market is segmented on the basis of type into smaller than 100 mm, 100-150 mm, and larger than 150 mm; on the basis of application into hospital, clinic, outpatient operating room; and on the basis of region into North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) and Middle East & Africa (MEA).
Some Of The Growth Factors Of This Market:
- Increasing prevalence of chronic venous insufficiency and varicose veins in the aging population is expected to drive the growth of the global sclerotherapy needle market.
- Increasing awareness about minimally invasive procedures for treatment of varicose veins and chronic venous insufficiency is also expected to fuel the growth of this market.
- The increasing number of new product launches in this segment are also anticipated to boost the demand for sclerotherapy needles globally.
- The high cost associated with these products may hamper their adoption.
Industry Growth Insights published a new data on “Sclerotherapy Needle Market”. The research report is titled “Sclerotherapy Needle Market research by Types (Smaller Than 100 mm, 100 - 150 mm, Larger Than 150 mm), By Applications (Hospital, Clinic, Outpatient Operating Room, Other), By Players/Companies Boston Scientific, Conmed Corporation, STERIS, Shaili Endoscopy, STD Pharmaceutical Products Ltd, Diagmed Healthcare, Blueneem, TeleMed Systems?Inc., Kangmei Company, Sugimandi, Medline Industries, Inc.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Sclerotherapy Needle Market Research Report
By Type
Smaller Than 100 mm, 100 - 150 mm, Larger Than 150 mm
By Application
Hospital, Clinic, Outpatient Operating Room, Other
By Companies
Boston Scientific, Conmed Corporation, STERIS, Shaili Endoscopy, STD Pharmaceutical Products Ltd, Diagmed Healthcare, Blueneem, TeleMed Systems?Inc., Kangmei Company, Sugimandi, Medline Industries, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Sclerotherapy Needle Market Report Segments:
The global Sclerotherapy Needle market is segmented on the basis of:
Types
Smaller Than 100 mm, 100 - 150 mm, Larger Than 150 mm
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Outpatient Operating Room, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific
- Conmed Corporation
- STERIS
- Shaili Endoscopy
- STD Pharmaceutical Products Ltd
- Diagmed Healthcare
- Blueneem
- TeleMed Systems?Inc.
- Kangmei Company
- Sugimandi
- Medline Industries, Inc.
Highlights of The Sclerotherapy Needle Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Smaller Than 100 mm
- 100 - 150 mm
- Larger Than 150 mm
- By Application:
- Hospital
- Clinic
- Outpatient Operating Room
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sclerotherapy Needle Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sclerotherapy needles are long, thin tubes made of metal or plastic that are inserted into the skin to inject a solution that hardens and seals the blood vessels. This procedure is used to treat varicose veins, spider veins (small, deep veins near the surface of the skin), and other types of vein problems.
Some of the key players operating in the sclerotherapy needle market are Boston Scientific, Conmed Corporation, STERIS, Shaili Endoscopy, STD Pharmaceutical Products Ltd, Diagmed Healthcare, Blueneem, TeleMed Systems?Inc., Kangmei Company, Sugimandi, Medline Industries, Inc..
The sclerotherapy needle market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Sclerotherapy Needle Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Sclerotherapy Needle Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Sclerotherapy Needle Market - Supply Chain
4.5. Global Sclerotherapy Needle Market Forecast
4.5.1. Sclerotherapy Needle Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Sclerotherapy Needle Market Size (000 Units) and Y-o-Y Growth
4.5.3. Sclerotherapy Needle Market Absolute $ Opportunity
5. Global Sclerotherapy Needle Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Sclerotherapy Needle Market Size and Volume Forecast by Type
5.3.1. Smaller Than 100 mm
5.3.2. 100 - 150 mm
5.3.3. Larger Than 150 mm
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Sclerotherapy Needle Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Sclerotherapy Needle Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Outpatient Operating Room
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Sclerotherapy Needle Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Sclerotherapy Needle Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Sclerotherapy Needle Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Sclerotherapy Needle Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Sclerotherapy Needle Demand Share Forecast, 2019-2026
9. North America Sclerotherapy Needle Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Sclerotherapy Needle Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Sclerotherapy Needle Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Outpatient Operating Room
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Sclerotherapy Needle Market Size and Volume Forecast by Type
9.7.1. Smaller Than 100 mm
9.7.2. 100 - 150 mm
9.7.3. Larger Than 150 mm
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Sclerotherapy Needle Demand Share Forecast, 2019-2026
10. Latin America Sclerotherapy Needle Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Sclerotherapy Needle Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Sclerotherapy Needle Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Outpatient Operating Room
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Sclerotherapy Needle Market Size and Volume Forecast by Type
10.7.1. Smaller Than 100 mm
10.7.2. 100 - 150 mm
10.7.3. Larger Than 150 mm
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Sclerotherapy Needle Demand Share Forecast, 2019-2026
11. Europe Sclerotherapy Needle Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Sclerotherapy Needle Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Sclerotherapy Needle Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Outpatient Operating Room
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Sclerotherapy Needle Market Size and Volume Forecast by Type
11.7.1. Smaller Than 100 mm
11.7.2. 100 - 150 mm
11.7.3. Larger Than 150 mm
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Sclerotherapy Needle Demand Share, 2019-2026
12. Asia Pacific Sclerotherapy Needle Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Sclerotherapy Needle Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Sclerotherapy Needle Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Outpatient Operating Room
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Sclerotherapy Needle Market Size and Volume Forecast by Type
12.7.1. Smaller Than 100 mm
12.7.2. 100 - 150 mm
12.7.3. Larger Than 150 mm
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Sclerotherapy Needle Demand Share, 2019-2026
13. Middle East & Africa Sclerotherapy Needle Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Sclerotherapy Needle Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Sclerotherapy Needle Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Outpatient Operating Room
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Sclerotherapy Needle Market Size and Volume Forecast by Type
13.7.1. Smaller Than 100 mm
13.7.2. 100 - 150 mm
13.7.3. Larger Than 150 mm
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Sclerotherapy Needle Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Sclerotherapy Needle Market: Market Share Analysis
14.2. Sclerotherapy Needle Distributors and Customers
14.3. Sclerotherapy Needle Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Boston Scientific
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Conmed Corporation
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. STERIS
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Shaili Endoscopy
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. STD Pharmaceutical Products Ltd
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Diagmed Healthcare
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Blueneem
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. TeleMed Systems?Inc.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Kangmei Company
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Sugimandi
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Medline Industries, Inc.
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
